Gambardella, Jessica, Xu Jun Wang, John Ferrara, Marco Bruno Morelli, and Gaetano Santulli. “Cardiac BIN1 Replacement Therapy Ameliorates Inotropy and Lusitropy in Heart Failure by Regulating Calcium Handling”. Basic to Translational Science. American College of Cardiology Foundation Washington DC, 2020.
Publications
2020
Sardu, Celestino, Raffaele Marfella, Paolo Maggi, Vincenzo Messina, Paolo Cirillo, Vinicio Codella, Jessica Gambardella, et al. “Implications of AB0 Blood Group in Hypertensive Patients With Covid-19”. BMC Cardiovascular Disorders 20, no. 1 (2020): 1-10.
Amgalan, Dulguun, Thomas P Garner, Ryan Pekson, Xiaotong F Jia, Mounica Yanamandala, Victor Paulino, Felix G Liang, et al. “A Small-Molecule Allosteric Inhibitor of BAX Protects Against Doxorubicin-Induced Cardiomyopathy”. Nature Cancer 1, no. 3 (2020): 315-28.
Gambardella, Jessica, Angela Lombardi, Marco Bruno Morelli, John Ferrara, and Gaetano Santulli. “Inositol 1, 4, 5-Trisphosphate Receptors in Human Disease: A Comprehensive Update”. Journal of Clinical Medicine 9, no. 4 (2020): 1096.
Sardu, Celestino, Gaetano Santulli, Germano Guerra, Maria Consiglia Trotta, Matteo Santamaria, Cosimo Sacra, Nicola Testa, et al. “Modulation of SERCA in Patients With Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study”. Journal of Clinical Medicine 9, no. 2 (2020): 544.
Santulli, Gaetano. “In Acute HF, Intensive and Sustained Vasodilation Did Not Reduce a Composite of Death or HF Readmission at 180 Days”. Annals of Internal Medicine 172, no. 10 (2020): JC54.
Morelli, Marco B, Gaetano Santulli, and Jessica Gambardella. “Calcium Supplements: Good for the Bone, Bad for the Heart? A Systematic Updated Appraisal”. Atherosclerosis 296 (2020): 68-73.
Morelli, Marco Bruno, Christopher Chavez, and Gaetano Santulli. “Angiopoietin-Like Proteins As Therapeutic Targets for Cardiovascular Disease: Focus on Lipid Disorders”. Expert Opinion on Therapeutic Targets 24, no. 1 (2020): 79-88.
Santulli, Gaetano. “In AF and Stable CAD, Rivaroxaban Reduced Cardiovascular Events and Mortality More Than Rivaroxaban Plus an Antiplatelet”. Annals of Internal Medicine 172, no. 2 (2020): JC6.
Wang, Xujun, Marco Bruno Morelli, Alessandro Matarese, Celestino Sardu, and Gaetano Santulli. “Cardiomyocyte-Derived Exosomal MicroRNA-92a Mediates Post-Ischemic Myofibroblast Activation Both in Vitro and Ex Vivo”. ESC Heart Failure 7, no. 1 (2020): 285-89.